Marcus O. Muench, PhD
Research and Clinical Interests
My laboratory is interested in the development of cellular therapies for diseases affecting blood and liver. Our current focus is on the development of a stem cell therapy for hemoglobinopathies based on the use of induced pluripotent stem cells. We also study the early development of human stem cell populations with a focus on hematopoietic and hepatic stem cells found in the prenatal liver.
- Ye L, Muench MO, Fusaki N, Beyer AI, Wang J., Qi Z, Yu J, Kan YW. Blood cell derived induced pluripotent stem cells free of reprogramming factors generated by Sendai viral vectors. Stem Cells Transl. Med. 2013;2:558-566.
- Muench MO, Chen JC, Beyer AI, Fomin ME. Cellular Therapies Supplement: The peritoneum as an ectopic site of hematopoiesis following in utero transplantation. Transfusion 2011; 51:106S-117S.
- Fomin ME, Tai L, Bárcena A, Muench MO. Coexpression of CD14 and CD326 discriminate hepatic precursors in the human fetal liver. Stem Cells Dev. 2011; 20:1247-57.
- Bárcena A, Kapidzic M, Muench MO, Gormley M, Scott MA, Weier JF, Ferlatte C, Fisher SJ. The human placenta is a hematopoietic organ during the embryonic and fetal periods of development. Dev. Biol. 2009; 327:24-33.
- Muench MO, Ohkubo T, Smith CA, Suskind DL, Bárcena A. Maintenance of proliferative capacity and retroviral transduction efficiency of human fetal CD38-/CD34++ stem cells. Stem Cells Dev. 2006; 15:97-108.
- 2001 NIH Research Career Award from NIDDK
- 2013 National Blood Foundation Scholar
- Associate Adjunct Professor
- Laboratory Medicine
- Division: Blood Systems Research Institute
- Phone: (415) 901-0747
- Blood Systems Research Institute
- 270 Masonic Ave.
- San Francisco, CA 94118
Other UCSF Organizational Association(s)
- Associate Member, UCSF Liver Center